Recently funded awards

This page lists the investigator-led programmes, projects and fellowships that we have recently supported through our response-mode grant funding schemes.

Select a funding committee to see what they have funded to date in 2023-24 (for Grant Award Letters issued up to January 2024):

November 2023

Biomarker Project Awards

Professor Ming-Qing Du (University of Cambridge)

Precision Prognostic Utility of MYC translocation in Aggressive B-cell lymphomas

Clinical Trial Awards

Dr Frederik van Delft (Newcastle University)

Hem-iSmart international early phase clinical trial platform

Professor Steven Knapper and Dr Richard Dillon (Cardiff University and Kings College London)

Optimise-FLT3 Study: Optimising therapy for patients with FLT3-mutated Acute Myeloid Leukaemia

Dr Fiona McDonald and Prof Judith Bliss (Institute of Cancer Research)

HALT - Targeted therapy with or without dose intensified radiotherapy for oligo-progressive disease in oncogene-addicted lung tumours (Costed Extension)


July 2023

Prospective Sample Collection Awards

Dr Anna Wilkins and Professor Emma Hall (Institute of Cancer Research)

3P sample collection application

Dr Ann Henry, Dr Finbar Slevin, Dr Alexandra Clipson (University of Leeds)

POINTER-PC SC: Evaluating molecular markers of radiotherapy efficacy and toxicity for pelvic nodal recurrence in prostate cancer

Dr Christopher Williams and Professor Andrew Beggs (University of Leeds)

ctDNA collection within the ARIEL trial: A biomarker enrichment trial of anti-EGFR agents in right primary tumour location, RAS wild-type, advanced colorectal cancer (aCRC)

Clinical Trial Awards

Professor Gordon Jayson and Professor Richard Adams (University of Manchester)

VALTIVE1b: Validation of Tie2 for VEGF inhibitors in Patients With Ovarian Cancer Treated With Olaparib and Bevacizumab Maintenance Therapy: Optimising the Design (Costed Extension)

Professor Michael Schmid, Professor Paula Ghaneh, Dr Ainhoa Mielgo, Professor Daniel Palmer (University of Liverpool)

Investigating the translational potential of inhibiting AXL in combination with adjuvant chemotherapy in the treatment of pancreatic cancer. (Pre-Clinical Package)

Experimental Medicine Awards

Professor Louis Chesler, Professor Darren Hargrave and Dr Isidro Cortés-Ciriano (Institute of Cancer Research)

Stratified Medicine Paediatrics 2 (StratMedPaediatrics2)

March 2023

Clinical Trial Awards

Professor Darren Hargrave, University of Birmingham

CRUK/23/002: BIOMEDE 2.0: Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

Dr Reuben Benjamin, Professor Christina Yap, Dr Charlotte Graham, Dr John Maher, King's College Hospital NHS Foundation Trust

CRUK/23/003: pCAR19: Phase 1, open label, dose escalation study evaluating the safety and efficacy of next generation anti-CD19 parallel chimeric antigen receptor T cells (pCAR19) in patients with relapsed/refractory B-cell lymphomas

Prospective Sample Collection Awards

Dr Elizabeth Phillips, Dr Kim Linton, University of Manchester

RADAR sample collection: a randomised phase III study with a PET response-adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previously untreated stage IA/IIA Hodgkin lymphoma

November 2023

​​Programme Awards

New Programmes

Professor Linda Wooldridge (University of Bristol)

Identification of antigens targeted by T-cells mediating Graft-versus-Leukaemia and Graft-versus-Host Disease following Stem Cell Transplantation

Renewing Programmes

Professor Pascal Meier (Institute of Cancer Research)

Harnessing Cell Death Mechanisms in Cancer

Professor Peter McHugh and Professor Christopher Schofield (University of Oxford)

Targeting nucleases for the treatment of cancer

Professor Jussi Taipale (University of Cambridge)

Identification and targeting of common regulatory mechanisms underlying major forms of human cancer

Programme Foundation Awards

Dr Luca Magnani (Institute of Cancer Research)

Disarming Dormancy: preventing evolution by targeting oestrogen receptor dormant cells in healthy and cancer tissues (DiDo)

Dr Nicholas McGranahan (University College London)

Dissecting Evolutionary phenotypes in Cancer by Investigating Plasticity and Heritability in Evolution and Resistance (DECIPHER)

Dr Audrey Gerard (University of Oxford)

Studying the coevolving cancer and immune landscapes – unravelling targetable pathways of immune adaptation

Dr Helen Rowe (Queen Mary University of London)

Crosstalk between chromatin remodelling and immune evasion in non-small cell lung cancer (NSCLC)

Multidisciplinary Project Awards

Professor Campbell Roxburgh, Professor Joanne Edwards and Professor Emiliano Spezi (University of Glasgow and Cardiff University)

Derivation of novel non-invasive radiomic and AI-based classifiers to determine molecular behaviour of rectal cancer and its treatment response to radiotherapy

Professor Oscar Ces and Professor Charlotte Bevan (Imperial College London)

Cancer Research UK & Prostate Cancer UK Innovation Award: Microenvironment-Remodelling Synthetic Cells for Cancer Drug Delivery (DRCMDP-May23/100012 and RIA22-ST2-010)

Cancer Immunology Project Awards

Dr Ricardo Fernandes (University of Oxford)

Identification of structural and functional correlates of robust antitumour T cell responses


June 2023

​​Programme Awards

New Programmes

Professor Katrin Ottersbach, University of Edinburgh

The role of the microenvironment in the initiation and maintenance of infant leukaemia

Dr Ingo Ringshausen, University of Cambridge

Oncogene & tumour suppressor-mediated remodelling of the tumour microenvironment in B cell lymphoproliferative diseases

Professor Simona Parrinello, University College London
Glioblastoma Initiation and Re-initiation

Renewing Programmes

Professor Christian Siebold, University of Oxford

Molecular Mechanisms of Morphogen Signalling in the Tumour Microenvironment

Professor Mark Cragg, Professor Stephen Beers, University of Southampton
Targeting myeloid cells for improved antibody immunotherapy

Professor Ronald Hay, University of Dundee

New players in the targeted degradation of the PML-RARA oncogene by arsenic

Programme Foundation Awards

Dr Christopher Tape, University College London

Treatment Analysis via Individualised Organoid Responses (TAILOR)

Multidisciplinary Project Awards

Dr Ran Yan, Dr John Maher, Dr James Arnold, Prof Erik Arstad, Kings College London

Development of Novel 18F-labelled Molecular Probes for Long-Term CAR T-cell Tracking with Positron Emission Tomography (CART_PET)

Cancer Immunology Project Awards

Professor Jessica Strid, Imperial College London

Contribution of bioactive lipid mediators to inflammation and epithelial cancer development

November 2023

Programme Awards

Professor David Weller, University of Edinburgh & Professor Peter Sasieni, Queen Mary University of London 
Risk-based screening in UK colorectal cancer screening programmes

Project Awards

Dr Massimiliano di Pietro, University of Cambridge & Dr Florian Markowetz, CRUK Cambridge Institute
Artificial intelligence based early detection of signet ring cell carcinoma in hereditary diffuse gastric cancer patients

Dr Ruchi Gupta, University of Birmingham
Smart Hydrogels and Devices for Early Detection of Cancer

Dr James Flanagan, Imperial College London
The Cancer Loyalty Card Study (CLOCS)

Dr Sarah Bailey, University of Exeter
Clinical utility of neutrophil-to-lymphocyte ratio in identifying patients at risk of cancer diagnosis in primary care: a cohort study using routine electronic health records

Professor Daryl O'Connor & Professor Mark Conner, University of Leeds
Increasing FIT bowel cancer screening uptake: Testing the effectiveness of two promising behaviour change interventions and their combination

Dr Rachel Evans & Dr Gilbert Fruhwirth, King's College London
ROR1 Detection As An Early Indicator Of Lung Cancer

Primer Awards

Dr Harriet Quinn-Scoggins, Cardiff University
Preparing healthcare providers and the public for Multi Cancer Early Detection (MCED) blood tests: towards equitable implementation through co-creation

Dr Vasiliki Symeonidou, University of Cambridge
Improving early detection of individuals at high-risk of developing AML and related cancers

Dr Jihong Zhu, University of York & Dr Roisin Bradley, York and Scarborough Teaching Hospital NHS Foundation Trust
Robotic Positioning Assistance in Breast Screening

Dr Stephanie Archer, University of Cambridge
Integrating multifactorial risk assessment within secondary care breast services: co-designing a new pathway

Dr Kirsten Christensen-Jeffries, King's College London
Advanced Ultrasound Imaging for Early Cancer Detection and Diagnosis

Dr Takanori Kitamura, University of Edinburgh
Identification of macrophage-associated biomarkers to predict the progression of ductal carcinoma in situ (DCIS) into invasive breast cancer

Professor Martin Widschwendter, University College London
Establishing optimal and acceptable vaginal self-sampling for epigenetic-based endometrial cancer surveillance in women with Lynch Syndrome

Dr Jamie Weaver & Dr Susanne Flach, LMU Klinikum Munich
Understanding the timings of mutations and microenvironmental changes in head and neck squamous cell carcinoma and associated field cancerization to develop better biomarkers for high-risk patient surveillance and early detection

Dr Hector Huerga Encabo & Professor Dominique Bonnet, The Francis Crick Institute
Detection of early steps of blood cancer


May 2023

Project Awards

Professor Peter Murchie, University of Aberdeen
Achieving Self-directed Integrated Cancer Aftercare (ASICA) in melanoma: Optimising the intervention using pilot evidence, assisted intelligence and behavioural science

Professor Shankar Balasubramanian & Professor Rebecca Fitzgerald, University of Cambridge
Evaluation of G-quadruplex profiling for the early detection of oesophageal adenocarcinoma

Dr Ana Rio-Machin & Dr Kevin Rouault-Pierre, Queen Mary University of London 
Deciphering the role of germline variants in the RNA-helicases to improve the early detection and management of familial MDS/AML patients

Dr Professor Richard Shaw & Professor Peter Weightman, University of Liverpool
Clinical and technical validation of infrared absorbance spectra to predict malignant transformation in oral potentially malignant disorders (OPMDs)

Dr Daniel Royston & Professor Jens Rittscher, University of Oxford
Integrating AI-based early detection and assessment of myeloproliferative neoplasms (MPN) into routine clinical pathways

Dr Lizhe Zhuang & Professor Rebecca Fitzgerald, University of Cambridge
Cross-platform study of clonal heterogeneity and microenvironmental niches in initiation and progression of Barrett’s oesophagus and oesophageal adenocarcinoma

Primer Awards

Dr Abish Stephen, Professor Keith Hunter & Dr Geraint Morgan, Queen Mary University of London
Volatile metabolomics for early detection of aerodigestive cancers

Dr Xin Yang, University of Cambridge
Improving endometrial cancer risk prediction for prevention and early detection

Professor David Klenerman & Professor Richard Mair, University of Cambridge
Sensitive detection of P53 aggregates in biofluids  for  the early detection of cancer

Dr Luca Panariello & Dr Adam Creamer, Imperial College London
MagnetoCrisprZyme sensor for quantification of circulating microRNA in primary care settings

Dr Marta Canel, University of Edinburgh
Validating new models to investigate the impact of mutational heterogeneity in the early detection of pancreatic cancer

Professor Neil Hunt, University of York
Ultrafast 2D-IR analysis of liquid biopsies for cancer detection

Dr Marek Palace, Dr Christian von Wagner & Dr Carlos Santos Barea , Liverpool John Moores University
Developing multimodal data-driven art-inspired bowel cancer-screening promotion messages

Dr Ljiljana Fruk, University of Cambridge
Senescence-detecting, urine-based nanobiosensor for early detection of lung cancer

Professor Trevor Graham & Dr Callum Gabbutt, Institute of Cancer Research
Sensitive and specific pan-cancer early detection using fluctuating methylation clocks


November 2022

Programme Awards

Professor Caroline Dive & Dr Phil Crosbie, University of Manchester
Development of a multi-modal liquid biopsy for the early detection of lung cancer

Professor Clare Turnbull, Institute of Cancer Research, Dr David Adams, Wellcome Sanger Institute, and Dr Greg Findlay, The Francis Crick Institute
Defining the compendium of pathogenic germline alleles in cancer susceptibility genes via multiplex assays of variant effect (CG-MAVE)

Project Awards

Dr Jacqueline Shields, King's College London
Exploiting The Lymphatic System For Early Detection And Risk Stratification Biomarkers

Dr James Reading, Professor Sam Janes & Dr Maxine Tran, University College London
A multiomic T cell differentiation index (TEDI) for non-invasive early detection of lung and renal cancer

Primer Awards

Dr Gwen Murphy, Imperial College London
Serologic biomarkers of stomach cancer precursor lesions

Dr James Yarmolinsky, University of Bristol
Using reverse Mendelian randomization to discover novel circulating biomarkers for early detection of cancer

Dr Emma Woodward, University of Manchester
ATLAS - eArly deTection in Li frAumeni Syndrome

Professor Paula Mendes, University of Birmingham
Using superselective glycan-binding nanoparticles to create a clinical assay for early ovarian cancer detection

Dr Patrick Kierkegaard, Imperial College London
Developing an equity-focused Target Product Profile for non-invasive biomarker tests tailored to support mobile testing outreach programmes to reduce cancer inequalities


May 2022

Programme Awards

Professor Fiona Walter, Queen Mary, University of London, & Professor Stephen Pereira, University College London
CANDETECT: Accelerating detection of upper gastro-intestinal (UGI) cancers using a multi- cancer early detection platform in primary care

Project Awards

Professor Sam Janes, Dr Amy Webster and Professor Christina Thirlwell, University College London    
Epi-ASCENT: The epigenetic landscape of screen-detected lung cancers

Dr Rasha Abu-Eid, University of Aberdeen 
Integrating Raman spectroscopy and digital pathology as a novel tool for objective grading of oral epithelial dysplasia

Dr Floor Christie-de Jong, University of Sunderland, & Professor Katie Robb, University of Glasgow
Improving uptake of breast, bowel and cervical cancer screening among Muslim women: a feasibility study of a peer-led, faith-based intervention

Primer Awards

Dr Richard Hopkinson, University of Leicester
Detection of aldehyde cancer biomarkers by harnassing their carcinogenic reactivity

Dr Alexander Oldroyd, University of Manchester   
The MyoScreen Study - Investigating the Utility of Liquid Biopsy as a Method of Early Detection of Idiopathic Inflammatory Myopathy-Associated Cancer

Dr Francesco Boccellato, University of Oxford    
Early detection of gastric cancer by the identification of functional markers driving pre- malignant alterations of the tissue

Dr Lauren Ford, Imperial College London  

Dr James Flanagan, Imperial College London 
Combining diet and symptom management for earlier detection of cancer using transactional data

Dr Samantha Hiu Yan Ip, University of Cambridge    
Investigating transportability of cancer detection models across datasets and time using population-wide electronic health data    

Dr Jennifer Heaney, University of Birmingham  
Improving myeloma diagnosis using a simple rapid test

Dr Denitza Williams, Cardiff University  
Novel decision support intervention to support choice in cervical screening modality

Dr Qiang Wang, University of Edinburgh 
Towards in-vivo in-situ early lung cancer detection using fluorescence lifetime imaging endomicroscopy: a preliminary study on data-driven characterisation of lung cancer using label-free autofluorescence lifetime images on unstained lung cancer tissue

Dr Sarah Haywood-Small, Sheffield Hallam University
Vocs-box breathomics: early detection and diagnosis of mesothelioma

Dr Leonid Nikitenko, University of Hull    
EARLY DIAPAC: EARLY DIAgnosis of PAncreatic Cancer by combined proteomics and genomics testing of pancreatic cyst fluid
Dr Christopher Rowlands, Imperial College London 
Cancer Led Optical Ultrasound Detection    

Dr Christian von Wagner, University College London   
Development and evaluation of a chatbot to support informed choice in the UK Bowel Cancer Screening Programmes

Professor Ferdia Gallagher, University of Cambridge  
Early detection of structural and metabolic changes in small renal masses using advanced MRI to differentiate benign from malignant lesions

Dr Ardhendu Behera, Edge Hill University 
LungHealth AI: Using AI to improve early detection and diagnosis of lung cancer

November 2023

Programme Awards

Professor Christopher Bunce & Professor Mark Drayson, University of Birmingham
Prevention not cure: An interdisciplinary approach to preventing Myeloma

Project Awards

Professor Mark Hamer, University College London
The twenty-four hour physical behaviour spectrum and risk of cancer: The Prospective Physical Activity, Sitting and Sleep consortium (ProPASS)

Professor Catherine Harwood & Dr Rubeta Matin, Cardiff University
SPOT-IT: cutaneous SCC Prevention using tOpical Therapy in Immunosuppressed patienTs

Dr Laura Woods & Professor Linda Sharp, Newcastle University
Investigating deprivation-specific and ethnic inequalities in adherence to endocrine therapy in women with ER+ve breast cancer: can these explain disparities in survival?

Professor Rosalind Eeles, Institute of Cancer Research
IMPACT: Identification of Men with a genetic predisposition to ProstAte Cancer: Targeted screening in men at higher genetic risk and non-carriers – Long term follow up of the Mis-match Repair Gene Cohort

Biology to Prevention Awards

Dr James Reading & Professor Sam Janes, University College London
Targeting early T cell regulation to intercept lung squamous carcinogenesis

Dr Seth Coffelt & Dr Joanne Edwards, University of Glasgow
Investigating immunological prevention strategies for precursor lesions of colon cancer

Professor Tim Elliott. Dr Kevin Litchfield & Professor Sarah Blagden, University of Oxford
LungVax: Preventing lung cancer via targeting hotspot neoantigens with the ChAdOx vaccine platform

Dr Stephanie May, University of Glasgow
Targeting oncogene induced anti-apoptotic pathways for precision prevention in liver cancer

Dr Sanne van Neervan & Professor Benjamin Simons, University of Cambridge
The role of mutant cell competition and cooperation during field cancerization and intestinal adenoma development

Dr Emma Allott, Queen's University Belfast
Repurposing statins for precision prevention of PTEN-null prostate cancer

Dr Yi Feng, University of Edinburgh
Tracing somatic cell acquired oncogenic mutations from inception to investigate tissue environmental contribution to preneoplastic development

Dr Matthew Rose-Zerilli, University of Southampton
Harnessing the activities of gastro-intestinal innate immune cells for the prevention of oesophageal adenocarcinoma

Dr Matthew Ford & Professor James Brenton, CRUK Cambridge Institute
Exploring premalignant lesions of high-grade serous ovarian cancer and response to next generation PARP-inhibitors


May 2023

Project Awards

Dr James Yarmolinsky, University of Bristol
Obesity and pancreatic cancer risk: leveraging genetic, observational, and molecular approaches to provide novel insights into causal intermediates to inform cancer prevention

Professor Richard Martin, Professor Jenny Donovan, Professor Freddy Hamdy & Professor David Neal, University of Bristol
Answering key questions needed to inform prostate cancer screening policy: long-term follow-up of the ProtecT (15-year) and CAP (18-year) randomised controlled trials.

Professor Doug Easton, University of Cambridge
Characterisation of novel breast cancer susceptibility genes through large-scale targeted sequencing

Biology to Prevention Awards

Professor Walid Khaled & Dr Sara Pensa, University of Cambridge
Targeting BRCA driven premalignant cellular changes in the breast

Professor Kwee Yong, University College London
Understanding and restoring NK cell (dys)function in smouldering myeloma to optimise intervention strategies to prevent development of multiple myeloma


November 2022

Project Awards

Renewing Programme

Professor Amanda Cross, Imperial College London
Screening, Prevention and Diagnosis of Gastrointestinal Cancer

Project Awards

Professor Chris Cardwell, Queen's University Belfast
Antibiotic use and survival from breast cancer

Dr Jamie Hartmann Boyce & Dr Nicola Lindson, University of Oxford
Synthesising evidence on e-cigarettes: two living systematic reviews exploring their efficacy and safety for smoking cessation, and how to stop using them

Dr Tom Dudding & Dr Barry Main, University of Bristol
Head and neck 5000 – Identifying factors affecting survival and secondary physical effects of treatment at 10 years

Dr Laura Woods, Newcastle University
Developing a screening engagement index (SEI) for England

Dr Toral Gathani, University of Oxford
The Associations of Ethnicity and Breast Cancer


May 2022

Programme Awards

Professor Claudia Allemani and Professor Michel Coleman, London School of Hygiene and Tropical Medicine
Global surveillance of cancer survival (CONCORD-4): 20-year trends in survival from 22 adult cancers and all childhood cancers, for patients diagnosed during 2000-2019 or later

Project Awards

Dr Simon Lord and Professor Sarah Blagden, University of Oxford
Exploring metformin’s mechanisms of action in mTP53-driven cancers

Professor Shahid Khan and Professor Simon Rushbrook, Imperial College London
Asp-PSC: Effect of Aspirin on Reducing Cancer in Primary Sclerosing Cholangitis

Dr Crawford Moodie, University of Stirling
The Adult Tobacco Policy Survey: Understanding how smokers and ex-smokers respond to tobacco control policies in the UK

Professor Nicholas Timpson and Dr Vanessa Tan, University of Bristol
Role of directly measured metabolic profile as an intermediate between adiposity and endometrial cancer: triangulation of evidence from independent sources

November 2023

Career Establishment Award

Dr Zarnie Khadjesari, University of East Anglia
Preventing cancer and cancer disparities with weight-management support – using hospital patient records and electronic signposting (eSIGN)

Dr Luigi Ombrato, Queen Mary University of London
Controlling metastasis formation by inhibiting the crosstalk between different myeloid cells

Dr Nischalan Pillay, University College London
Neo-Sarc: Enhancing the clinical whole genome sequencing programme for patients with genomically complex sarcomas

Career Development Award

Dr Matthew Coelho, Wellcome Sanger Institute
Establishing the Genetic Landscape of Therapy Resistance in Lung Cancer with Gene Editing

Dr Anke Nijhuis, Imperial College London
Targeting RNA splicing as a novel therapeutic strategy in ovarian cancer

Dr Johan Vande Voorde, University of Glasgow 
Leveraging microbial metabolism to improve clinical outcome in colorectal cancer

Pre-doctoral Research Bursary

Dr Thineskrishna Anbarasan, University of Oxford
Integrating Spatial Transcriptomics with Multiparametric MRI in Prostate Cancer

Dr Faiz Jabbar, Imperial College Healthcare NHS Trust
Investigating how non-mutagenic factors influence driver gene selection during cancer initiation

Dr Thurkaa Shanmugalingam, King's College London
Profiling circulating tumour cells in lobular breast cancer

Dr Daniel Hughes, University College London
Modelling chromosome 13 deletion in human myeloma cell lines for functional assessment

Postdoctoral Research Bursary

Dr Oliver Pickles, University of Birmingham
Establishing a Patient-Derived Explant (PDE/PDTF) Programme for Colorectal Cancer Liver Metastases to Enhance Responses to Immune Checkpoint Blockade


May 2023

Senior Cancer Research Fellowship

Dr Ivana Bjedov, University College London
Defining novel mechanisms of selective radioprotection to improve cancer radiotherapy

Dr Andrew Blackford, University of Oxford
Genetic and functional interactions of RecQ helicases in cancer

Advanced Clinical Science Fellowship

Dr Amaya Viros, Cancer Research UK Manchester Institute
Melanoma metabolic programmes of metastasis, tropism and immunotherapy response by anatomic site

Career Establishment Award

Dr Mirjana Efremova, Queen Mary, University London
Characterising the cellular state transitions mediating colorectal cancer metastasis

Clinician Scientist Award

Dr Sarah Aitken, University of Cambridge
Identifying image biomarkers in the spatial evolution of liver cancer

Pre-doctoral Research Bursary

Dr Khaylen Mistry, University of East Anglia
Molecular characteristics and outcomes of melanoma in England: a national cohort study

Dr Riccardo Masina, University of Cambridge
Modelling drug response with multi-omics using machine learning in PDTC high-throughput drug screening

Dr Daniele Scotto, University of Nottingham
Characterisation of myeloid-derived suppressor cells as a therapeutic target in glioblastoma multiforme

Dr Georgios Solomou, Cambridge University Hospitals NHS Trust
Delineating glioblastoma cell state transitions during cell invasion using a patient-derived glioblastoma ex vivo organoid model (GBO)

Postdoctoral Research Bursary

Dr Thomas Hubbard, University of Exeter
Investigating the changes in breast cancer post neoadjuvant chemotherapy with Raman Spectroscopy

Dr Akshay Patel, University of Birmingham
Investigating Regulatory B cells as determinants of immune-related adverse events following checkpoint blockade therapy

Dr Robert Morgan, University of Manchester
Exploiting a Living Biobank to develop targeted therapies for platinum-resistant ovarian cancer


November 2022

Career Establishment Award

Dr Barrie Peck, Queen Mary, University of London
Understanding and exploiting Acetyl-CoA metabolism in Small Cell Lung Cancer

Senior Cancer Research Fellowship

Dr Jörg Mansfeld, Institute of Cancer Research
Discovery and functional investigation of how ROS can regulate the cell cycle

Clinician Scientist Fellowship

Dr Ayesha Noorani, Wellcome Sanger Institute 
Mapping the clonal dynamics and somatic mutations of the human oesophagus during disease, development and carcinogenesis

Dr Sung Pil Hong, Imperial College London
Single-cell multi-omic profiling of intratumoral heterogeneity to tackle oesophageal cancer cell adaptation to chemotherapy

Dr Gurdeep Mannu, University of Oxford
Pre-invasive and Invasive breast cancer: from risk factors to optimal treatment


May 2022

Career Establishment Award

Dr Manavendra Pathania, University of Cambridge 
The role of partner mutations in histone-mutant paediatric glioma

Dr Oscar Rueda, University of Cambridge
A statistical dynamic system for breast cancer prognosis and patient monitoring

Senior Cancer Research Fellowship

Dr Sophie Acton, University College London
Harnessing the lymphoid tissue niche to boost anti-tumour immunity 

Clinician Scientist Fellowship

Dr Ehsan Ghorani, Imperial College London 
Deciphering mechanisms of immune dysfunction and immunotherapy sensitivity in gestational trophoblastic neoplasia 

Advanced Clinician Scientist Fellowship

Dr Jyoti Nangalia, Wellcome Sanger Institute
Deciphering timelines and trajectories to blood cancer 

More facts and figures about our research funding

Facts and figures about our research funding

Find out more about how and where we supported research in the last year with our interactive map and infographics.

Funding committees

Successful applicant case studies

Find out how our current grantees successfully applied for funding.

Read more

Awards funded in FY2021-2022

See list of awards funded in FY2021-2022